Bg pattern

SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

SICCAFLUID 2.5 mg/g OPHTHALMIC GEL IN UNIT DOSE

Carbomer 974 P

Read this package leaflet carefully because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If your symptoms worsen or persist, you should consult your doctor.
  • If you think any of the side effects that you are suffering from is serious or if you notice any side effect not mentioned in this package leaflet, inform your doctor or pharmacist.

Contents of the Package Leaflet

  1. What is Siccafluid and what is it used for
  2. Before using Siccafluid
  3. How to use Siccafluid
  4. Possible side effects
  5. Storage of Siccafluid
  6. Further information

1. What is Siccafluid and what is it used for

Siccafluid is a tear substitute and contains a lubricant called Carbomer 974P.

It is an ophthalmic gel used for the relief of symptoms of dry eyes (such as inflammation, burning, irritation, or dryness) caused when the eyes do not produce enough tears.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Before using SICCAFLUID

Do not use Siccafluid

•If you are allergic (hypersensitive) to carbomer or any of the other components of Siccafluid listed in section 6, "What contains Siccafluid".

Be careful with Siccafluid

If your condition worsens or does not improveafter starting treatment with Siccafluid, contact your doctor.

•DO NOT INJECT, DO NOT INGEST.

Children and adolescents up to 18 years of age

The safety and efficacy of SICCAFLUID in children and adolescents at the recommended posology for adults have been established based on clinical experience, but no clinical studies are available.

Use of other medications

Tell your doctor or pharmacist if you are using or have recently used other medications, including those purchased without a prescription.

If you need to use any other ophthalmic medication during treatment with Siccafluid: first use the other ophthalmic medication and wait 15 minutes before using Siccafluid.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using any medication.

If you are pregnant or breastfeeding, contact your doctor to consult before starting the use of Siccafluid.

He or she will decide if you can use Siccafluid.

Driving and using machines

Your vision may become blurry for a short time after using Siccafluid.

You should not drive or use machinery until your vision returns to normal.

3. How to use Siccafluid

If you have been recommended Siccafluid for use, follow exactly the administration instructions indicated by your doctor. Consult your doctor or pharmacist if you have doubts.

The doseusuallyis 1 drop administered in the affected eye or eyesup to4 times a day.

Children and adolescents up to 18 years of age

The safety and efficacy of SICCAFLUID in children and adolescents at the recommended posology for adults have been established based on clinical experience, but no clinical studies are available.

How to use:

Wash your hands before opening the unit dose container.

Check that the gel is at the tip of the container. To open the container, turn until the tab on the top breaks.

Tilt your head back and look up.

Eye showing drop application, first eye open, then dropper approaching and finally drop deposited

  1. Gently pull down the lower eyelid of the affected eye until a small "pouch" forms.
  2. Turn the container upside down. Press until a drop falls into the "pouch".
  3. Release the lower eyelid and blink several times.
  4. Repeat steps 1 to 3 in the other eye if it also needs to be treated.

To help prevent infection, do not touch the eye, surrounding areas, or any other area with the tip of the container.

Discard the unit dose container after use. Do not save it for later use.

If you use more Siccafluid than you should

Using more drops of Siccafluid than you should does not cause any harm.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20.

If you forget to use Siccafluid

Do not use a double dose to make up for the forgotten dose. Apply the next dose according to the frequency you have established.

If you have any other questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medications, Siccafluid can cause side effects, although not everyone gets them.

Contactyour doctor if:

•Your symptoms worsen or do not improve after starting treatment with Siccafluid.

If you experience any of the following side effects after applying the ophthalmic gel to the eye, talk to your doctor if it concerns you:

•Transient blurred vision

•Mild itching or burning sensation in the eye.

The side effects mentioned may occur, but the number of people likely to be affected may vary.

Reporting side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this package leaflet. You can also report them directly through the Spanish Medicines Monitoring System: https://notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Siccafluid

Keep out of the reach and sight of children.

Do not use Siccafluid 2.5 mg/g ophthalmic gel after the expiration date that appears on the container and on the box after CAD. The expiration date is the last day of the month indicated.

Do not store above 25°C. Keep the unit dose containers in the original packaging to protect them from light.

Discard the unit dose container with the remaining solution immediately after use.

Do not save for later use.

Medications should not be thrown away through wastewater or household waste. Deposit the containers and medications you no longer need at the SIGRE collection point in the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need.In this way, you will help protect the environment.

6. Further information

Composition of Siccafluid

  • The active ingredient is Carbomer 974 P 2.5mg/g.
  • The other ingredients are sorbitol, lysine monohydrate, sodium acetate trihydrate, polyvinyl alcohol, and water for injection.

Appearance of the product and container contents

Siccafluid is a slightly yellowish opalescent gel in unit dose containers.

Each unit dose container contains 0.5 g of gel.

Each box contains 10, 20, 30, or 60 unit dose containers (not all presentations may be marketed).

Marketing authorization holder

LABORATORIOS THEA S.A.

C/ Enric Granados, nº 86-88, 2ª planta, 08008 Barcelona

Manufacturer

LABORATOIRES UNITHER

1 RUE DE L’ARQUERIE 50200 COUTANCES

FRANCE

OR

LABORATOIRES UNITHER

INDUSTRIAL AREA NORTH

151, RUE ANDRÉ DUROUCHEZ – BP 28028

80084 AMIENS CEDEX-2

FRANCE

This medication is authorized in the member states of the European Economic Area under the following names:

France, Spain, Italy, and Portugal: ……………………………….. SICCAFLUID

Netherlands …………………………………………………… SICCAFLUID UNIDOSE

Iceland and Norway …………………………………………….. OFTAGEL

This package leaflet was approved in March 2015

Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/

Online doctors for SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE

Discuss questions about SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE?
SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE?
The active ingredient in SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE is artificial tears and other indifferent preparations. This information helps identify medicines with the same composition but different brand names.
How much does SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE cost in pharmacies?
The average pharmacy price for SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE is around 7.02 EUR. Prices may vary depending on the manufacturer and dosage form.
Who manufactures SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE?
SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE is manufactured by Laboratorios Thea S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to SICCAFLUID 2.5 mg/g OPHTHALMIC GEL SINGLE-DOSE?
Other medicines with the same active substance (artificial tears and other indifferent preparations) include ACUOLENS 3 mg/ml + 5.5 mg/ml EYE DROPS IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS IN SOLUTION IN SINGLE-DOSE CONTAINERS, ARTIFIC 3.20 mg/ml EYE DROPS SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media